AdvisorShares Psychedelics ETF
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
AdvisorShares Psychedelics ETF earns a Neutral rating, supported by a 36.0 composite score and moderate 3/5 conviction. The regulatory pillar provides the strongest contribution at 55.0, led by a 70.0 global-jurisdiction posture and an 80.0 enforcement subscore. Fundamentals contribute 40.0 despite unavailable company-level financial data, while editorial registers 30.0 on limited coverage. Market conditions represent the principal constraint at 15.0, reflecting the weak liquidity signal. The resulting profile places PSIL in the Neutral band: regulatory exposure offers relative support, but absent fundamentals, thin trading activity, and sparse newsroom engagement prevent a more constructive rating.
Revenue growth and margin trends remain unavailable because the fund lacks a usable fundamentals record in the supplied licensed fundamentals data. That absence limits assessment of portfolio-level operating momentum and leaves the financial condition classified as unknown. Filing cadence is also weak: primary regulatory filings show no latest filing date, no regulatory events during either the latest 90-day or 180-day period, and a cadence subscore of 25.0. The lack of enforcement hits supports the stronger 80.0 enforcement reading, although that clean record does not offset the stale cadence signal. Institutional pricing feeds record zero volume, producing a 15.0 liquidity subscore and confirming the market pillar as the largest drag. CIN newsroom coverage contains no newsroom hits or brief hits, leaving both editorial subscores at 30.0.
The clearest path toward an improved composite runs through the regulatory pillar, already the fund’s strongest source of support. A fresh primary regulatory filing or a documented jurisdictional development would strengthen cadence, validate the favorable global posture, and create a measurable catalyst for both editorial attention and market participation. With no recent events in either observed window, the regulatory score currently rests more heavily on jurisdiction and the absence of enforcement hits than on active disclosure. The single most important signal to watch is the appearance of a new primary regulatory filing that lifts the cadence subscore from its current low level.
- Phone
- 1.877.843.3831
- Website
- Company website
- Beta
- 0.56
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
AdvisorShares Psychedelics ETF (PSIL): ETF Overview
AdvisorShares Psychedelics ETF is a cannabis-sector exchange-traded fund tracked by Cannabis Investor News. Holdings, top weights, fund flows, and performance metrics are updated alongside live pricing.
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for PSIL are maintained by Cannabis Investor News and refreshed throughout the trading day.